What is LCDX stock price today?

LCDX (Caliber Imaging & Diagnostics Inc) stock is trading at $0.00 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is LCDX stock going up or down today?

LCDX stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy LCDX stock now?

The decision to buy LCDX depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is LCDX a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for LCDX based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is LCDX stock overvalued or undervalued?

Use our DCF valuation calculator to determine if LCDX is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is LCDX's P/E ratio?

P/E ratio data for LCDX will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is LCDX's market cap?

LCDX (Caliber Imaging & Diagnostics Inc) has a market capitalization of $0.00 billion, making it a small-cap stock.

What is LCDX's price to book ratio?

Price-to-book ratio for LCDX is available on our dashboard along with other valuation metrics.

Does LCDX pay dividends?

LCDX does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is LCDX's dividend yield?

LCDX does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is LCDX stock a good long-term investment?

LCDX's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is LCDX's revenue growth rate?

LCDX has shown revenue growth of -0.2% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

LCDX is currently operating at a loss. Some companies prioritize growth over profitability in early stages. Review our financial analysis for detailed insights.

What are the risks of investing in LCDX?

Key risks for LCDX include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does LCDX compare to its competitors?

Compare LCDX to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize LCDX's performance and positioning.

What is LCDX's stock price target for 2026?

Our AI model provides price targets for LCDX based on fundamental analysis: Bull case $0.00 (+30%), Base case $0.00 (+15%), Bear case $0.00 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about LCDX?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for LCDX. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is LCDX's next earnings report?

LCDX reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

LCDX - Caliber Imaging & Diagnostics Inc

NYSE * Healthcare * Medical Devices

$0.00

+$0.00 (+0.00%)

About Caliber Imaging & Diagnostics Inc

Caliber Imaging & Diagnostics, Inc., a medical technologies company, designs, develops, and markets imaging solutions that shows tissue at the cellular level in the United States. The company provides VivaScope 1500, a reflectance confocal imaging system that enables clinicians and researchers to capture confocal images that depict cellular structures of living tissue; and VivaScope 3000, a hand-held in vivo reflectance confocal microscope for skin imaging. It also offers VivaScan software to schedule patients for examinations, perform imaging examinations on one or more lesions during a visit, review, and report on images obtained during an examination, as well as VivaNet, a digital telepathology system. Caliber Imaging & Diagnostics, Inc. was formerly known as Lucid, Inc. and changed its name to Caliber Imaging & Diagnostics, Inc. in August 2012. The company was founded in 1991 and is headquartered in Andover, Massachusetts.

LCDX Key Statistics

Market Cap

$0.01M

000

Revenue Growth

-0.2%

Profit Margin

-2.0%

Employees

How LCDX Compares to Peers

LCDX is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

of 6

Growth Rank

of 6

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
LCDX(This stock)	$5.10K	N/A	-0%	-2.0%	-
ABTAbbott Laboratories	$168.23B	26.7	0%	0.1%	vs ABT
MDTMedtronic Plc	$110.66B	23.9	0%	0.1%	vs MDT
SYKStryker Corp	$131.49B	40.8	0%	0.1%	vs SYK
BSXBoston Scientific	$95.46B	33.1	0%	0.1%	vs BSX
ISRGIntuitive Surgical	$166.65B	59.5	0%	0.3%	vs ISRG

Caliber Imaging & Diagnostics Inc Company Information

Headquarters: 100 Burtt Road, Andover, MA, United States, 01810, undefined
Website: www.caliberid.com
Sector: Healthcare
Industry: Medical Devices

About Caliber Imaging & Diagnostics Inc

LCDX Key Statistics

How LCDX Compares to Peers

Caliber Imaging & Diagnostics Inc Company Information

Upcoming Events for LCDX